Literature DB >> 3177644

[3H]saxitoxin as a marker for canine deep muscular plexus neurons.

S Ahmad1, H D Allescher, H Manaka, Y Manaka, E E Daniel.   

Abstract

The objectives of this study are 1) to examine the potential of [3H]saxitoxin binding as a marker for the neuronal membranes in canine small intestinal muscle membrane preparations, 2) to develop a synaptosomal preparation from deep muscular plexus, and 3) to partially characterize [3H]saxitoxin binding to this fraction. A purified synaptosomal fraction, relatively low in the smooth muscle plasma membrane marker enzyme 5'-nucleotidase but enriched in [3H]saxitoxin binding (2,592 fmol/mg), was obtained on sucrose density gradient. Vasoactive intestinal peptide immunoreactivity was also highest (51.82 pmol/mg protein) in this fraction. The binding was rapid at 20 degrees C with quick and complete dissociation after the addition of excess unlabeled tetrodotoxin (TTX). Scatchard analysis of the saturation binding data revealed a single population of binding sites (Bmax = 5,705 fmol/mg protein). The affinity constants calculated from the kinetic and saturation data were in close agreement (Kd = 0.26 and 0.69 nM, respectively). TTX competed for the binding (Ki = 2.1 nM), whereas veratridine and guanidinium hydrochloride did not. Monovalent and divalent cations had differential effects on the binding.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177644     DOI: 10.1152/ajpgi.1988.255.4.G462

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Identification and characterization of high-affinity Ca2(+)-ATPase associated with axonal plasma membranes of dog mesenteric nerves.

Authors:  P Kostka; W H Barnett; C Y Kwan
Journal:  Neurochem Res       Date:  1990-08       Impact factor: 3.996

2.  Subcellular-membrane characterization of [3H]ryanodine-binding sites in smooth muscle.

Authors:  Z D Zhang; C Y Kwan; E E Daniel
Journal:  Biochem J       Date:  1993-02-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.